Status:

RECRUITING

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Lead Sponsor:

Perceive Biotherapeutics, Inc.

Conditions:

Age-Related Macular Degeneration

Geographic Atrophy

Eligibility:

All Genders

60+ years

Phase:

PHASE1

PHASE2

Brief Summary

The Phase 1 safety study of VOY-101 comprises of escalating dose Cohorts, followed by a Phase 2a.

Detailed Description

This is a prospective, open-label, multi-center Phase 1/2a study to evaluate the safety of a single, unilateral intravitreal (IVT) injection of escalating dose levels of VOY-101 therapy in subjects wi...

Eligibility Criteria

Inclusion

  • Are ≥60 years of age at the time of consent.
  • Are willing and able to understand and provide written informed consent.
  • Are willing and able to return for scheduled treatment and follow-up examinations.
  • Are able to undergo ETDRS BCDVA testing and ophthalmic imaging.
  • Well-demarcated GA secondary to AMD in the absence of MNV and in the absence of history of MNV for both eyes.
  • Absence of signs of non-exudative MNV.
  • Additional Ocular Inclusion Criteria for both eyes.
  • Meet certain genotype criteria for risk of AMD.

Exclusion

  • Are women of childbearing potential (WOCBP) and are pregnant or unwilling to use and document use of effective contraception for the duration of the study.
  • Additional Systemic, Ocular, and Genetic Exclusion Criteria.

Key Trial Info

Start Date :

June 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2028

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06087458

Start Date

June 21 2023

End Date

March 1 2028

Last Update

October 15 2025

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Retina Macula Institute of AZ

Scottsdale, Arizona, United States, 85255

2

The Retina Partners

Encino, California, United States, 91436

3

Retinal Consultants Medical Group

Sacramento, California, United States, 95825

4

Retina Consultants San Diego

San Diego, California, United States, 92064

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration | DecenTrialz